In this study, we evaluated 6 lung adenocarcinoma patients with FISH-negative and Ventana IHC-positive ALK results, 3 of whom were validated with RT-PCR technology, including 2 who were also validated with NGS and RNAscope ISH methods. The gene discussed is ALK; the disease is lung adenocarcinoma.